Clinical Trials Directory

Trials / Conditions / Stage IIIB Bladder Cancer AJCC v8

Stage IIIB Bladder Cancer AJCC v8

7 registered clinical trials studyying Stage IIIB Bladder Cancer AJCC v8.

StatusTrialSponsorPhase
Active Not RecruitingTesting Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemo
NCT04963153
National Cancer Institute (NCI)Phase 1
Active Not RecruitingTocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or
NCT04940299
M.D. Anderson Cancer CenterPhase 2
Active Not RecruitingARID1A and/or KDM6A Mutation and CXCL13 Expression
NCT04953104
M.D. Anderson Cancer CenterPhase 2
TerminatedPlinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progress
NCT04902040
M.D. Anderson Cancer CenterPhase 1 / Phase 2
CompletedRemote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes
NCT04501913
City of Hope Medical Center—
CompletedAvelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Partici
NCT03617913
Mayo ClinicPhase 2
CompletedPembrolizumab in Treating Patients With Bladder Cancer Undergoing Radical Cystectomy
NCT03319745
M.D. Anderson Cancer CenterPhase 2